Overexpression of the chemokine stromal-derived factor 1 α (SDF-1/CXL12) and its receptor CXCR4 is a hallmark of many hematological malignancies, including AML, and generally correlates with a poor prognosis. The gene discussed is CXCL12; the disease is acute myeloid leukemia.